Thursday 5th November 2020
|Text too small?|
The provisional result of the Cannabis Referendum announced on Friday 30 October has driven significant discussion in the media and in the community. The discussion has highlighted that the difference between medicinal cannabis and recreational cannabis is still not widely understood.
That lack of clarity has meant there has been an incorrect view that Rua Bioscience, which is a licenced Medicinal Cannabis company, is impacted by the outcome (either a yes vote or a no vote) of the Cannabis Referendum. This is not the case.
Ahead of the final result from the Cannabis Referendum being announced, the directors of Rua Bioscience believe it is important to clearly restate that the company’s strategy set out in the Product Disclosure Statement is to develop and primarily export pharmaceutical grade medicinal cannabis products.
Rua Bioscience has no plans to enter the recreational cannabis market if cannabis is legalised in New Zealand beyond the current provisions for medicinal cannabis.
Rua Bioscience is solely focussed on medicinal cannabis. Rua Bioscience is licenced under the Medicinal Cannabis Access Scheme, which came into effect on 1 April 2020. In August, Rua was granted one of the first commercial licences for cultivation, possession for manufacturing and supply of pharmaceutical cannabis.
Source: Rua Bioscience Limited (NZX: RUA )
No comments yet
Greenfern Industries Limited (Greenfern) Normanby Power Station Gets Green Light
Just Life Group Limited (NZX: JLG) to Acquire Business of About Health and Raise Capital
Tourism Holdings Limited (NZX: THL) Market Update
Delegat Group Limited (NZX: DGL) 2021 Harvest Announcement
Kiwi Property Group Limited (NZX: KPG) Gives Green Light to New Sylvia Park Office Building
Just Life Group Limited (NZX: JLG) Invests in Domestic Rainwater Tank Business
NZME Limited (NZX: NZM) NZ Markets Disciplinary Tribunal Censures
Rua Bioscience Limited (NZX: RUA) Announces CCO with Global Pharma Experience
Cannasouth Limited (NZX: CBD) Supply Activity Added to Cannasouth Commercial Licence
Skellerup Holdings Limited (NZX: SKL) Upgrades FY21 Earnings Guidance